Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease.

Russell RL, Siedlak SL, Raina AK, Bautista JM, Smith MA, Perry G. Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease. Arch Biochem Biophys. 1999 Oct 15; 370(2):236-9.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Aged, 80 and over
Alzheimer Disease
Case-Control Studies
Child
Child, Preschool
Cytoplasm
Glucosephosphate Dehydrogenase
Humans
Middle Aged
Oxidative Stress
Pentose Phosphate Pathway
Pyramidal Cells
Sulfhydryl Compounds

authors with profiles

George Perry

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support